Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' tumors, according to early data in a first-in-people clinical trial.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1xFufjH
from Today's Healthcare News -- ScienceDaily http://ift.tt/1xFufjH
No comments:
Post a Comment